No 10Y consistency score yet for revenue — the window needs more comparable quarters.
Valuation vs own 10Y history: P/S 1.1x · 10Y median 1.4x · 38th percentile · as of Oct 6, 2026
Annualized revenue (TTM) · by quarter, last 23
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Quote observation: 2026-10-06T21:27:59.496Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Quote observation: 2026-10-06T21:27:59.496Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow. Quote observation: 2026-10-06T21:27:59.496Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Quote observation: 2026-10-06T21:27:59.496Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Unrounded diluted TTM EPS / FMP quote price × 100. Quote observation: 2026-10-06T21:27:59.496Z. Latest historical point 2026-10-05.
Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Quote observation: 2026-10-06T21:27:59.496Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter operating cash flow / FMP quote market capitalization × 100. Quote observation: 2026-10-06T21:27:59.496Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter free cash flow / FMP quote market capitalization × 100. Quote observation: 2026-10-06T21:27:59.496Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
The latest delayed quote for Pagaya Technologies Ltd. (PGY) stock was $18.05 as of Oct 6, 2026, 4:00 PM EDT, down 1.90% from the previous close.
Longer view (total return, dividends reinvested): past 12 months -37.3% · 3-year avg -0.8%/yr · 5-year avg -31.1%/yr
Pagaya Technologies Ltd. is a financial technology enterprise operating across Israel, the United States, and the Cayman Islands.
Software - Infrastructure · New York, NY
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
Next Earnings Date
Nov 9, 2026
34 days away
EPS Estimate
0.47
Revenue Est.
$382.30M
Last Quarter Results
EPS
$1.07
vs Estimate
$0.72
Revenue
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1PGY | $1.51B | $18.05 | -1.90% | -37.27% | -31.14% | N/A | N/A |
| 2ALKT | $1.51B | $14.11 | -0.28% | -42.30% | -11.01% | N/A | vs PGY |
| 3CNXC | $1.52B | $24.84 | -3.98% | -43.66% | -30.54% | N/A | vs PGY |
| 4PRGS | $1.53B | $37.20 | -0.04% | -19.30% | -4.90% | +4.16% | vs PGY |
| 5MGRT | $1.49B | $108.00 | +4.84% | +2013.01% | N/A | N/A | vs PGY |
| 6CRSR | $1.46B | $13.64 | +0.81% | +68.07% | -12.09% | N/A | vs PGY |
2.53
$387.04M
vs Estimate
$356.02M
Consensus Rating
Based on 11 analysts
Average Price Target
$28.91
+60.2% upside
Low
$23.00
Current
$18.05
High
$36.00
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $0.45 | $0.47 | $0.51 | 5 |
| Quarter ending Dec 2026 | $0.45 | $0.47 | $0.51 | 5 |
| Quarter ending Mar 2027 | $0.42 | $0.44 | $0.47 | 3 |
| Quarter ending Jun 2027 | $0.59 | $0.61 | $0.66 | 3 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2026 | $1.63 | $1.67 | $1.73 | 6 |
| FY 2027 | $2.26 | $2.32 | $2.40 | 6 |
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $379.31M | $382.30M | $385.28M | 6 |
| Quarter ending Dec 2026 | $368.51M | $378.07M | $387.64M | 6 |
| Quarter ending Mar 2027 | $365.37M | $376.83M | $399.06M | 3 |
| Quarter ending Jun 2027 | $432.58M | $446.15M | $472.47M | 3 |
Annual
| Period |
|---|
Source: FMP Analyst Consensus Estimates. Forward P/E uses the consensus EPS estimate for the fiscal year ending Dec 31, 2026, matching Key Metrics.
| Low |
|---|
| Avg |
|---|
| High |
|---|
| # Analysts |
|---|
| FY 2026 | $1.46B | $1.47B | $1.49B | 8 |
| FY 2027 | $1.68B | $1.71B | $1.72B | 8 |
